Semaglutide shows early bone-building signal in male mice study
An exploratory mouse study found that 28 days of semaglutide exposure significantly increased the osteoblast-covered bone surface without detectable changes in trabecular…
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 28 07:55 ETSource: Bioengineer.org
From the source
Read at bioengineer.orgSemaglutide shows early bone-building signal in male mice study
An exploratory mouse study found that 28 days of semaglutide exposure significantly increased the osteoblast-covered bone surface without detectable changes in trabecular microarchitecture or dynamic bone formation indices.
